ADX10059 Migraine Prevention Study

This study has been terminated.

( Incidence of abnormalities of liver function tests is higher than expected in this population. )

Study NCT00820105 Information provided by Addex Pharma S.A.

First Received: January 8, 2009 Last Updated: December 23, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)